Average Co-Inventor Count = 3.34
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (13 from 4,179 patents)
2. Abbvie Inc. (3 from 822 patents)
3. Other (1 from 832,843 patents)
4. Mediver Ab (1 from 1 patent)
5. Abbvie Bahamas Limited (6 patents)
6. Abbvie Ireland Unlimited Company (0 patent)
18 patents:
1. 9580410 - 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
2. 8835647 - 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
3. 8399468 - Octahydro-pyrrolo[3,4-B]pyrrole derivatives
4. 8372987 - 2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
5. 7968707 - Retroviral protease inhibiting compounds
6. 7728031 - Octahydro-pyrrolo[3,4-b]pyrrole derivatives
7. 7491718 - Sulfonamides having antiangiogenic and anticancer activity
8. 7279582 - Retroviral protease inhibiting compounds
9. 7074932 - Preparation of quinoline-substituted carbonate and carbamate derivatives
10. 6579986 - Preparation of quinoline-substituted carbonate and carbamate derivatives
11. 6472529 - Retroviral protease inhibiting compounds
12. 6417366 - Preparation of quinoline-substituted carbonate and carbamate derivatives
13. 6313296 - Retroviral protease inhibiting compounds
14. 6184376 - Synthesis of acyclic nucleoside derivatives
15. 5319105 - Derivatives and anologs of monoethylglycinexylidide